HALO
Halozyme Therapeutics, Inc. · Healthcare
President and CEO Helen Torley sold $1.7M of Halozyme Therapeutics, Inc.
Sold$1,706,440
$56.88Price
30,000Shares
−4%Stake
What HALO did after the filing
- The stock from Fri, Sep 27 open, $57.35
- +6.3%
- S&P 500, same days
- +4.3%
Measured over 30 trading days, to the Nov 8 close.
Traded Tue, Sep 24. Filed Thu, Sep 26, 6:06 PM ET, after the close. Returns use the Sep 27 open and the Nov 8 close. Not investment advice.